top of page

Class III Medical Devices: The ÜTS Document Set and Clinical Evidence

Clinical investigation requirements for Class III medical devices, the consultation procedure, the SSCP and the document set ÜTS expects. A pre-application checklist.


A blockage in the ÜTS registration of a Class III device usually comes not from a missing field but from a missing document, and that document is usually a report the manufacturer says "we already have" but never sent you. The set ÜTS expects in this class is not just the certificate and the declaration of conformity; the clinical evidence chain of the device also has to be consistent with the record.

This page sets out, point by point, the weight carried by Class III and implantable devices: what is done for each device in the conformity assessment, from whom the summary of safety and clinical performance (SSCP) is requested, under which conditions the clinical investigation obligation falls away, which document business rule ÜTS runs for this class, and the points that need separate checking before the application. Everything written rests on the provisions of the Medical Device Regulation (Tıbbi Cihaz Yönetmeliği) published in the Official Gazette No. 31499 (bis) of 2/6/2021 and the Manual on Registration Procedures of Medical Devices in the Product Tracking System (Tıbbi Cihazların Ürün Takip Sistemine Kayıt Süreçlerine İlişkin Kılavuz).

There is no representative device in Class III; every device is examined one by one

In the lower classes, part of the conformity assessment runs through a representative device. In Class III this convenience does not exist. Article 52(3) of the Medical Device Regulation says that manufacturers of class III devices, other than custom-made or investigational devices, are subject to a conformity assessment as specified in Annex IX; alternatively, the manufacturer may choose to apply a conformity assessment as specified in Annex X coupled with a conformity assessment as specified in Annex XI.

Article 61(7)(a) of the Manual clarifies the same route: manufacturers of Class-III devices are subject to the conformity assessment as specified in MDR Annex IX, that is, to the MDR Annex IX (Chapter II) conformity assessment for each device, together with MDR Annex IX (Chapters I and III). Point (b) of the same paragraph says that, as an alternative, a conformity assessment based on type-examination as specified in MDR Annex X may be applied, coupled with a conformity assessment under MDR Annex XI (Part A) or MDR Annex XI (Part B).

Point 4 of Annex IX says in its heading that the assessment of the technical documentation applies to class III devices and to the class IIb devices referred to in Article 52(4)(b). Point 4.1 of Annex IX says that, in addition to the manufacturer's quality management system obligations, the manufacturer lodges an application with the notified body for assessment of the technical documentation relating to the device it plans to place on the market or put into service. Point 4.9 of Annex IX defines the outcome: if the device conforms to the relevant provisions of the Regulation, the notified body issues an EU technical documentation assessment certificate; this certificate contains the conclusions of the technical documentation assessment, the conditions of validity of the certificate, the data needed for identification of the approved design and, where appropriate, a description of the intended purpose of the device.

The practical result is this: in Class III, the certificate set you hold must contain a document in which the name of your device appears. A quality management system certificate that carries only a device group description cannot be the whole chain in this class.

The expectation of clinical evidence is at the centre of the conformity assessment

In Class III, the notified body's review is not limited to checking documents. Point 4.4 of Annex IX says that the notified body reviews the clinical evidence presented by the manufacturer in the clinical evaluation report; that it employs device reviewers with sufficient clinical expertise; and that, where necessary, it consults external clinical experts with direct and current experience of the device or of the clinical condition in which it is used.

Point 4.5 of Annex IX says that, where the clinical evidence is based partly or fully on data from devices claimed to be equivalent, the notified body assesses the suitability of using such data, taking into account factors such as new indications and innovation, and clearly documents its conclusions. Point 4.6 of Annex IX says that this verification includes assessment of the benefit-risk determination, of risk management, of the instructions for use, of user training and of the adequacy of the manufacturer's post-market surveillance plan. Point 4.8 of Annex IX says that the notified body clearly documents the outcome of its assessment in a clinical evaluation assessment report.

Point 4.10 of Annex IX also sets a rule for the period after registration: changes to the approved device that could affect the safety and performance of the device or the conditions prescribed for its use require approval from the notified body that issued the EU technical documentation assessment certificate. In Class III, a change to a product has to be dealt with on the certificate side before the ÜTS update.

The clinical investigation obligation and the three exemption conditions

Article 61(4)(a) of the Medical Device Regulation sets the rule directly: for implantable devices and class III devices, clinical investigations must be performed unless all of the following conditions are met. Three conditions are required together: the device has been designed through modifications of a device already marketed by the same manufacturer; the manufacturer has demonstrated that the modified device is equivalent to the marketed device in accordance with point 3 of Annex XIV, and this demonstration has been endorsed by the notified body; and the clinical evaluation of the marketed device is sufficient to demonstrate conformity of the modified device.

Point (b) of the same paragraph says that, where a clinical investigation is not required, the notified body verifies that the post-market clinical follow-up plan is appropriate and includes post-market studies to demonstrate the safety and performance of the device.

Article 61(6) of the Medical Device Regulation excludes two groups of devices from this obligation entirely. Point (a) of the same paragraph covers implantable devices and class III devices that were lawfully placed on the market or put into service under the Medical Device Regulation and the Active Implantable Medical Devices Regulation repealed by Article 110, and whose clinical evaluation is based on sufficient clinical data. Point (b) of the same paragraph lists sutures, staples, dental fillings, dental braces, tooth crowns, screws, wedges, plates, wires, pins, clips and connectors whose clinical evaluation is based on sufficient clinical data.

Article 61(7) of the Medical Device Regulation says that these exemptions are not free of charge: cases where paragraph 4 does not apply under paragraph 6 are justified in the clinical evaluation report by the manufacturer and in the clinical evaluation assessment report by the notified body. That is, if the exemption is being used, its justification is written down, and that justification must be in the file.

Clinical evaluation consultation and the expert panel

For class III implantable devices an additional layer enters the conformity assessment. Article 54(1)(a) of the Medical Device Regulation says that, for class III implantable devices, the notified body also follows the procedure relating to the clinical evaluation consultation, as specified in point 5.1 of Annex IX or point 6 of Annex X, as applicable.

Point 5.1(a) of Annex IX describes this procedure: after verifying the quality of the clinical data supporting the manufacturer's clinical evaluation report, the notified body prepares a clinical evaluation assessment report setting out its conclusions on the clinical evidence provided by the manufacturer, especially as regards the benefit-risk determination, the consistency of this evidence with the intended purpose and the post-market clinical follow-up plan, and submits this report, together with the manufacturer's clinical evaluation documentation, to the Commission for transmission to the expert panel.

Article 54(2) of the Medical Device Regulation lists three cases in which consultation is not required: in the case of renewal of a certificate issued under this Regulation; where the device has been designed by modification of a device already marketed by the same manufacturer for the same intended purpose and the manufacturer demonstrates, to the satisfaction of the notified body, that the modifications do not adversely affect the benefit/risk ratio; and where the clinical evaluation principles for the type or category of device have been addressed in a common specification and the notified body confirms conformity.

Paragraph 3 of the same article says that the notified body notifies the competent authorities, the Agency and the Commission, through the electronic system referred to in Article 57, whether or not this procedure has been applied, and that the notification is accompanied by the clinical evaluation assessment report.

Article 55(1) of the Medical Device Regulation then sets up the detailed review mechanism: the notified body notifies the competent authorities of the certificates it has granted to devices for which the conformity assessment was carried out under Article 54(1), and these notifications are accompanied by the summary of safety and clinical performance under Article 32, the notified body's assessment report and the instructions for use referred to in point 23.4 of Annex I.

SSCP: who prepares it, who validates it, where it is published

The summary of safety and clinical performance is a requirement specific to Class III and implantable devices. Article 32(1)(a) of the Medical Device Regulation says that this summary is drawn up by the manufacturer for implantable devices and class III devices, other than custom-made or investigational devices.

Point (b) of the same paragraph says that the summary is written in a way that is clear to the intended user and, if relevant, to the patient, and is made publicly available via EUDAMED. Point (c) of the same paragraph describes the process: the draft of the summary forms part of the documentation to be submitted to the notified body involved in the conformity assessment under Article 52 and is validated by that body; after validating the summary, the notified body uploads it to EUDAMED; the manufacturer mentions on the label or instructions for use where the summary is available.

This last sentence has a direct consequence for ÜTS registration. The label or instructions for use of the Class III device you register must carry information pointing to the summary; this information appears in the document uploaded to ÜTS together with the instructions for use.

Article 32(2) of the Medical Device Regulation lists the minimum content of the summary: information identifying the device and the manufacturer, including the Basic UDI-DI and, if already issued, the single registration number; the intended purpose, indications, contraindications and target populations; a description of the device, including a reference to previous generations or variants if such exist, and a description of the accessories; possible diagnostic or therapeutic alternatives; reference to any harmonised standards and common specifications applied; a summary of the clinical evaluation as referred to in Annex XIV and relevant information on post-market clinical follow-up; the suggested profile and training for users; and information on residual risks and undesirable effects, warnings and precautions.

The summary is not prepared once and left. Article 61(10) of the Medical Device Regulation says that, for class III devices and implantable devices, the post-market clinical follow-up evaluation report and, where applicable, the summary of safety and clinical performance referred to in Article 32 will be updated at least once a year.

The document set ÜTS expects for Class III

Article 66(1) of the Manual says that, for a device registration notification under the MDR, according to the type and risk class of the device, the appropriate one or ones of the documents mentioned in Articles 7, 11, 17, 20, 22, 23 and 24 of the Manual must be linked to the device. Paragraph 8 of the same article says that, for devices to be notified as "Class-III" under the MDR, the appropriate one of the document business rules shown in Annex-93 of the Manual will be run.

In this set the instructions for use are unconditional. The first sub-point of Article 17(2)(a) of the Manual says that, for Class-III and Class-IIb devices certified under the MDR and MDD, uploading to ÜTS the instructions for use issued by the manufacturer is mandatory. There is no accessory exemption either: paragraph 5 of the same article says that, for Class-IIb and Class-III devices that are accessories, if the manufacturer of the main device is different from the manufacturer of the accessory, the accessory's own instructions for use, or, if there are none, the instructions for use created by the manufacturer of the main device, will be uploaded without regard to criteria such as differences in notified body and address.

On the EU declaration of conformity side, Article 11(2)(ı) of the Manual comes into play: for EU declarations of conformity other than those whose scope covers only Class-I Other or Class A devices, the name and identification number of the notified body, a description of the conformity assessment procedure carried out and the identification of the EU certificate or certificates issued are required. These three pieces of information must be in a Class III declaration, and the certificate numbers must match the certificates you register in ÜTS.

On the EU certificate side, the first sub-point of Article 7(2)(h) of the Manual asks that, for EU technical documentation assessment certificates, EU type-examination certificates and EU product verification certificates, a clear description of the device including name, model and type, the intended purpose, the risk class and the Basic UDI-DI information be present. Point (m) of the same paragraph also counts conditions or limitations on the validity of the certificate as a mandatory field; this field is often filled in on Class III certificates, and its content must not contradict the ÜTS record.

What needs to be checked separately before the application

In Class III the pre-application checks are longer than in other classes. The points directly regulated in the source are these:

  • Application type selection: Article 40(3) of the Manual says that the list of device application types includes "Optical Products Application" ("Optik Ürünler Başvurusu"), "Active Implantable Medical Devices Application" ("Aktif İmplante Tıbbi Cihazlar Başvurusu"), "Class 3 Products Application" ("Sınıf 3 Ürünler Başvurusu"), "Other Products Application" ("Diğer Ürünler Başvurusu"), "Custom-Made Medical Device Application" ("Ismarlama Tıbbi Cihaz Başvurusu"), "System and Procedure Pack Application" ("Sistem İşlem Paketi Başvurusu") and "Products Under 2023/KK-1 & 2023/KK-2 Application" ("2023/KK-1 & 2023/KK-2 Kapsamında Ürünler Başvurusu"). Selecting the wrong application type for a Class III device is an error independent of the content of the application.

  • Implantability field: Article 27(7)(h) of the Manual says that selecting the "Is it implantable in the body?" field is mandatory; the third sub-point of the same point says that, when this field is selected "Yes", ÜTS automatically marks the "Is it single-use?" and "Is there a limited number of uses?" fields as "Yes" and the "Limited Number of Uses" field as "1", and that no change can be made in these fields. The third sub-point of point (j) of the same paragraph also states expressly that the limited number of uses of implantable and single-use devices is 1.

  • Basic UDI-DI unity: Article 40(8) of the Manual says that, in device applications under the New Medical Device Regulations (except custom-made devices), applications are allowed only for devices linked to the same Basic UDI-DI code.

  • Single declaration link: Article 40(5)(c) of the Manual says that medical device applications can be formed only from devices linked to a single declaration, and that only one declaration can be selected from the list.

  • Complete upload of the certificate: Article 7(6) of the Manual requires that the EU certificate be uploaded and submitted to the Agency in full, with all its annexes and additional pages. Since the list of covered devices in Class III certificates is mostly in the annex, a missing annex is directly a scope problem.

  • Barcode identical to the document: The fourth sub-point of Article 27(2)(b) of the Manual says that a device application made under Article 40 of the Manual for a device record whose barcode is not entered into ÜTS as it appears in its technical documents ends negatively.

  • Notified body being defined in ÜTS: Article 7(7) of the Manual says that, if the notified body that issued the certificate is not defined in ÜTS, a request is opened from the "Submit Request" ("Talep Bildir") screen before document registration operations, and the body is added to ÜTS as a result of a NANDO query.

There is also the cost of correcting the class afterwards. Article 43(7) of the Manual says that data change requests relating to fields requiring Agency assessment, such as "Class", "GMDN" and "EMDN", are in every case submitted to the Agency's assessment and approval; paragraph 11 of the same article says that, if as a result of updating the "Class" field the documents linked to the device records become inconsistent with the device class, revision data will be given to the devices with the relevant barcode.

Implant card and information to be given to the patient

For implantable Class III devices there is one more set of documents, independent of the ÜTS registration, delivered together with the device. Article 18(1) of the Medical Device Regulation says that the manufacturer of an implantable device provides together with the device: the information allowing identification of the device, including the device name, serial number, lot number, UDI and device model, together with the name, address and website of the manufacturer; any warnings, precautions or measures to be taken by the patient or a health professional; and information on the expected lifetime of the device and any necessary follow-up.

Paragraph 2 of the same article says that this information will be provided, in a way that allows rapid access by the patient in whom the device has been implanted, in Turkish and, where necessary, in English; that it will be written in a way that is easily understood by a layperson; and that manufacturers will provide the information in point (a) of paragraph 1 on an implant card supplied with the device.

Paragraph 4 of the same article gives the exemption list: sutures, staples, dental fillings, dental braces, tooth crowns, screws, wedges, plates, wires, pins, clips and connectors are exempt from the obligations in this article.

This set of documents is not uploaded to ÜTS as a separate document type, but its Turkish content has to be consistent with the instructions for use, and it is a set that is asked for in market surveillance inspections.

After registration: reporting and retention obligations increase

In Class III, registration is not the end of the obligations. Article 84(1)(b) of the Medical Device Regulation says that manufacturers of class IIb and class III devices update the periodic safety update report at least once a year, and that this report is part of the technical documentation as specified in Annexes II and III. Paragraph 2 of the same article says that, for class III devices or implantable devices, manufacturers submit these reports to the notified body involved in the conformity assessment under Article 52 through the electronic system referred to in Article 89; the notified body reviews the report and adds its own evaluation to the system.

The retention period also gets longer. Article 10(8)(a) of the Medical Device Regulation says that the technical documentation, the EU declaration of conformity and a copy of every relevant certificate are kept for at least 10 years after the last device has been placed on the market, and for implantable devices this period is at least 15 years. Point 7 of Annex IX repeats the same periods and counts, among the documents to be kept, the documentation referred to in point 4.2 of Annex IX and the decisions and reports of the notified body.

On the CE marking side, Article 20(5) of the Medical Device Regulation says that, where a notified body is responsible for the conformity assessment procedures, the CE marking is followed by the identification number of the notified body, and that this number is also shown on any promotional material stating that the device fulfils the requirements for CE marking. On Class III devices the four-digit number on the label is expected to be the same as the notified body identification number on the certificate registered in ÜTS.

What we do in a Class III file, and what we cannot do

Within medical device ÜTS registration consultancy, our concrete outputs on the Class III side are these:

  • Certificate set inventory: We separate the documents from the manufacturer into the Annex IX route and the Annex X and Annex XI combination, and we determine, according to Article 7(2)(h) of the Manual, whether the set contains a certificate that covers the device at the level of name and model.

  • Declaration and certificate cross-check: We compare the certificate numbers, the notified body name and the identification number in the EU declaration of conformity with the EU certificates registered in ÜTS.

  • SSCP consistency check: We check, according to Article 32(1)(c) of the Medical Device Regulation, whether the label or instructions for use contains a pointer to where the summary of safety and clinical performance is available.

  • Implant fields check: We make sure that the "Is it implantable in the body?" field and the automatic fields tied to it are consistent with the device and the instructions for use.

  • Application configuration: We set up the application type, the single-declaration link and the Basic UDI-DI unity under Article 40 of the Manual, and we bring the application to the point where it is ready for signature.

What we cannot do is clear as well. We cannot produce the clinical evaluation, the clinical investigation, the post-market clinical follow-up plan or the summary of safety and clinical performance on the manufacturer's behalf; Article 32(1)(a) of the Medical Device Regulation ties the summary to the manufacturer, and Article 61(1) ties the clinical evaluation to the manufacturer. Validating the summary is not our job either; point (c) of paragraph 1 of the same article gives this authority to the notified body, and it is the notified body that uploads the summary to EUDAMED. We cannot widen the notified body's certificate scope or intervene in the clinical evaluation consultation process; Article 54 of the Medical Device Regulation sets this procedure up between the notified body, the expert panel and the Commission.

The way of working is also set up according to this weight: the firm defines a user authorisation for us from its own ÜTS firm page, and we prepare the Class III document and device records with the "Medical Device Registration Operator" ("Tıbbi Cihaz Kayıt Elemanı") authorisation. Article 40(5)(g) of the Manual requires that, for the application to move to "Under Review" ("İncelemede") status, it must first be electronically signed by the firm's signatory. The regulatory responsibility on the side of clinical evidence and the safety summary is in every case with the manufacturer.

Tıbbi Cihaz ÜTS Kayıt Danışmanlığı

Request an ÜTS registration consultancy quote

Ehlibeyt Mahallesi, Tekstilciler Caddesi No: 35/7 06520 Çankaya / Ankara - TÜRKİYE

Cevizli Mahallesi, Zuhal Caddesi Ritim İstanbul B Blok, No:44 Maltepe / İstanbul - TÜRKİYE

info@medexmedikal.com
+90 505 580 4622
+90 312 389 1354

ÜTS Guides · Legislation Calendar · Glossary · ÜTS Guide Index · Frequently Asked Questions

Services: ÜTS Consultancy · Who Carries Out the ÜTS Registration? · ÜTS Document Registration Consultancy · ÜTS Product Registration Consultancy · Importer ÜTS Registration Consultancy · Sales Centre Authorisation Certificate · EUDAMED Registration Consultancy · MDR/IVDR Declaration of Conformity · Technical File Preliminary Review · Label and Instructions for Use Check · PRRC Service · PMS and PSUR · Clinical Evaluation · EMDN and GMDN Code Determination · Certificate of Free Sale · EUDAMED XML Generator · ÜTS Registration Training · Correction of a Rejected ÜTS Application

KVKK and Privacy Policy | Cookie Policy | Accessibility Statement

© 2026 Medex Kurumsal Danışmanlık Ltd. Şti.

bottom of page
WhatsApp Hemen Ara